Showing 1 - 20 results of 131 for search '"6-mercaptopurine"', query time: 0.12s Refine Results
  1. 1
  2. 2
  3. 3

    Toxicity evaluation of 6-mercaptopurine-Chitosan nanoparticles in rats by Prem Kumar Govindappa, Darukeshwara Joladarashi, Raghavendra Lakshmana Shetty Hallur, Jagadeesh S. Sanganal, Ayyalasomayajula Ratna Phani

    Published 2020-01-01
    “…Background: The 6-mercaptopurine (6-MP) is an effective immunosuppressant and anti-cancer drug. …”
    Get full text
    Article
  4. 4
  5. 5

    Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature by Maya Frank Wolf, Ronen Sloma, Luiza Akria, Eli Rimon, Yifat Wiener, Michal Carmiel Haggai, Lior Lowenstein

    Published 2023-09-01
    “…Objective: Azathioprine, a prodrug of 6-mercaptopurine (6-MP), is used in the treatment of inflammatory bowel disease and may be continued during pregnancy. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8
  9. 9

    Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine by Allon Kahn, Erika S. Boroff, Kari A. Martin, Donald W. Northfelt, Russell I. Heigh

    Published 2015-05-01
    “…We present the case of a patient with Crohn's disease with recurrent pancytopenia attributed to the surreptitious ingestion of 6-mercaptopurine. In patients with possible access to immunomodulatory drugs, a high suspicion for and early identification of factitious disorder may improve patient outcomes and avoid invasive and costly diagnostic evaluations.…”
    Get full text
    Article
  10. 10

    Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review by Carolina Rios-Usuga, Marlen Martinez-Gutierrez, Julian Ruiz-Saenz

    Published 2024-01-01
    “…The use of azathioprine (AZA) in human medicine dates back to research conducted in 1975 that led to the development of several drugs, including 6-mercaptopurine. In 1958, it was shown that 6-mercaptopurine decreased the production of antibodies against earlier administered antigens, raising the hypothesis of an immunomodulatory effect. …”
    Get full text
    Article
  11. 11

    Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system by Dorniani, Dena, Hussein, Mohd. Zobir, Kura, Aminu Umar, Fakurazi, Sharida, Shaari, Abdul Halim, Ahmad, Zalinah

    Published 2013
    “…The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. …”
    Get full text
    Article
  12. 12
  13. 13

    Effect of maintenance therapy for childhood with acute lymphoblastic leukaemia by combination of methotrexate and 6–mercaptopurine on the liver. by Abid T. Firas, Al–Fakhri F. Ilham

    Published 2005-12-01
    “… Seven of 30 children with acute lymphoblastic leukaemia (ALL) receiving maintenance therapy (MT) consisting of daily oral 6–mercaptopurine (6MP) and weekly methotrexate (MTX) developed both hepatocellular destruction and intrahepatic cholestasis (with abnormally elevated levels of serum aminotransferases enzymes GOT, GPT that mainly indicate liver cell destruction, and alkaline phosphatase, gammaglutamyl transferase enzymes, as well as total serum bilirubin that mainly indicate biliary tract disorder). …”
    Get full text
    Article
  14. 14

    Anti-arthritic effects of 6-mercaptopurine and its derivatives in arthritis-induced model, In vitro and In vivo by Che Ku Daud, Che Ku Dahlan

    Published 2020
    “…In this study, four thiopurine compounds namely, 6- mercaptopurine (6-MP), 6-MP riboside, 6-thioguanine (6-TG) and 6-thioxanthine (6- TX) with diclofenac (a non-steroidal anti-inflammatory drug; NSAID) as positive control were screened for their cytotoxicity and anti-inflammatory properties by evaluating the cell cytotoxicity and the nitric oxide (NO) inhibitory activities upon activated fibroblast synoviocytes (HIG-82) and macrophage (RAW 264.7) cell lines with phorbol-12- myristate acetate (PMA) and lipopolysaccharide (LPS), respectively. …”
    Get full text
    Thesis
  15. 15
  16. 16
  17. 17

    Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. by Vora, A, Mitchell, C, Lennard, L, Eden, T, Kinsey, SE, Lilleyman, J, Richards, S

    Published 2006
    “…BACKGROUND: 6-mercaptopurine has been a standard component of long-term continuing treatment for childhood lymphoblastic leukaemia, whereas 6-thioguanine has been mainly used for intensification courses. …”
    Journal article
  18. 18

    Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites by Orsolya Balázs, Ágnes Dombi, Balázs Z. Zsidó, Csaba Hetényi, Kateřina Valentová, Róbert G. Vida, Miklós Poór

    Published 2023-11-01
    “…In this study, we examined the impacts of luteolin, naringenin, myricetin, ampelopsin, and their sulfate/glucuronide derivatives on XO-catalyzed xanthine and 6-mercaptopurine oxidations employing in vitro enzyme incubation assays and molecular modeling studies. …”
    Get full text
    Article
  19. 19
  20. 20